RecruitingNCT06098495

Looking for a Blood Epigenetic Signature to Predict Female Infertility


Sponsor

Università Vita-Salute San Raffaele

Enrollment

1,456 participants

Start Date

Oct 16, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The present research project aims to study the DNAm mechanisms underlying the reduction of fertility due to the progressive depletion of oocyte quality. Specifically, our project aims to build an epigenetic clock for MGCs by using outcomes that are certainly related to female fertility. The validation of such findings will be carried out on peripheral blood in order to guarantee its non-invasiveness and allow for any clinical transferability. In order to identify a blood epigenetic signature able to predict female infertility, we planned to explore the problem from different points of view by conducting several studies in different settings.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 43 Years

Inclusion Criteria1

  • < age <43, Infertile woman undergoing ART, recurrent pregnancy loss

Exclusion Criteria1

  • age < 18 or > 44, previous ovarian surgery, severe male factor infertility

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICsearch for epigenetic profile of infertility

examine the epigenetic profile of DNA extracted from MGCs and blood sample


Locations(1)

Università Vita Salute San Raffaele

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06098495


Related Trials